Rosuvastatin/Amlodipine

rosuvastatin/amlodipine · Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rosuvastatin/Amlodipine, covering 2022-10-12 to 2022-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia [Phase 4]